These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 2274522)

  • 21. The effects of N-propyl-ajmaline hydrogen tartrate (NPAB), SPARTEINE SULFATE (SPARteine) and NPAB + sparteine on ECG and aconitine arrhythmias of SIV-rats.
    von Philipsborn G
    Arzneimittelforschung; 1973 Dec; 23(12):1729-33. PubMed ID: 4801683
    [No Abstract]   [Full Text] [Related]  

  • 22. [The effect of verapamil in coronary insufficiency and cardiac arrhythmia].
    Bobkova VI; Solomonova LN; Majorov JM; Karpickij VS; Mazurova SV
    Arzneimittelforschung; 1970 Sep; 20():Suppl 9a:1285+. PubMed ID: 4098327
    [No Abstract]   [Full Text] [Related]  

  • 23. The actions of verapamil on experimental arrhythmias.
    Rodrigues-Pereira E; Viana AP
    Arzneimittelforschung; 1968 Feb; 18(2):175-9. PubMed ID: 5695375
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical experiences with a new orally effective antiarrhythmic agent (Aprindin)].
    Breithardt G; Gleichmann U; Seipel L; Loogen F
    Z Kardiol; 1974 May; 63(3):435-44. PubMed ID: 4608660
    [No Abstract]   [Full Text] [Related]  

  • 25. Electrophysiologic actions of UM-272 (Pranolium) on reentrant ventricular arrhythmias in postinfarction canine myocardium.
    Gibson JK; Lucchesi BR
    J Pharmacol Exp Ther; 1980 Aug; 214(2):347-53. PubMed ID: 7391982
    [No Abstract]   [Full Text] [Related]  

  • 26. Protection against in vivo focal myocardial ischemia/reperfusion injury-induced arrhythmias and apoptosis by hesperidin.
    Gandhi C; Upaganalawar A; Balaraman R
    Free Radic Res; 2009 Sep; 43(9):817-27. PubMed ID: 19579067
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RSD1000: a novel antiarrhythmic agent with increased potency under acidic and high-potassium conditions.
    Yong SL; Xu R; McLarnon JG; Zolotoy AB; Beatch GN; Walker MJ
    J Pharmacol Exp Ther; 1999 Apr; 289(1):236-44. PubMed ID: 10087010
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Basic considerations of the treatment of cardiac arrhythmias].
    Valenzuela F
    Arch Inst Cardiol Mex; 1991; 61(5):451-4. PubMed ID: 1772318
    [No Abstract]   [Full Text] [Related]  

  • 29. A comparison of the antiarrhythmic actions of two new synthetic compounds, iproveratril and MJ 1999, with quinidine and pronethalol.
    Schmid JR; Hanna C
    J Pharmacol Exp Ther; 1967 May; 156(2):331-8. PubMed ID: 4381702
    [No Abstract]   [Full Text] [Related]  

  • 30. [Change of the fibrillation threshold of the heart of spontaneously breathing guinea pigs in hypothermia].
    Kirsch U
    Arzneimittelforschung; 1969 Mar; 19(3):312-3. PubMed ID: 5818779
    [No Abstract]   [Full Text] [Related]  

  • 31. [Studies on the modification of circulatory depressant effect of bradycardia-inducing drugs].
    Grisk A; Stremmel D
    Acta Biol Med Ger; 1968; 20(6):805-23. PubMed ID: 5723838
    [No Abstract]   [Full Text] [Related]  

  • 32. [The effect of a new anti-arrhythmia agent, a diethylamine analog of ethmozine, on the electrophysiological indices of the sinoatrial node in patients with its normal function and dysfunction].
    Rozenshtraukh LV; Shugushev KhKh; Smetnev AS
    Ter Arkh; 1983; 55(5):84-8. PubMed ID: 6351326
    [No Abstract]   [Full Text] [Related]  

  • 33. Beta receptor blocking and antiarrhythmic properties of tolamolol.
    Bagwell EE; Custy J; Steen RG; Newman WH
    J Pharmacol Exp Ther; 1974 Dec; 191(3):496-505. PubMed ID: 4154378
    [No Abstract]   [Full Text] [Related]  

  • 34. Antiarrhythmic and hemodynamic effects of prifuroline.
    Benharkate M; Plassard G; Legeai J; Worcel M
    Arzneimittelforschung; 1986 Dec; 36(12):1761-7. PubMed ID: 3566836
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Derivatives of 2-mercaptobenzenesulphonamide. XI. Synthesis and some pharmacological properties of 2-(2-[2-(3,4,5-trimethoxybenzamido)ethylthio] benzenesulphonyl) guanidines.
    Brzozowski Z; Sławiński J; Oledzka K; Kosmala M; Filczewski M; Lewandowski K; Miłobedzka J
    Acta Pol Pharm; 1993; 50(4-5):345-52. PubMed ID: 8036920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Anti-arrhythmic action of prilocaine].
    Carpinelli AR; Murari A; Nassif M; Valle LB; Oliveira Filho RM; Cãmara SA
    Arq Bras Cardiol; 1976 Apr; 29(2):89-92. PubMed ID: 952627
    [No Abstract]   [Full Text] [Related]  

  • 37. [Effects of denudatine on experimental arrhythmia and heart function (author's transl)].
    Jin LS; Zhou YP; Zeng GY
    Zhongguo Yao Li Xue Bao; 1982 Jun; 3(2):104-8. PubMed ID: 6214142
    [No Abstract]   [Full Text] [Related]  

  • 38. Derivatives of 2-mercaptobenzenesulphonamide. XII. Synthesis and some pharmacological properties of 2-(2-mercaptobenzenesulphonyl)imidazoline.
    Brzozowski Z; Sławiński J; Oledzka K; Kosmala M; Lewandowski K; Filczewski M; Miłobedzka J
    Acta Pol Pharm; 1993; 50(4-5):353-8. PubMed ID: 8036921
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Derivatives of 2-mercaptobenzenesulphonamide. XVII. Synthesis and some pharmacological properties of 1-[4-R-5-cyano-2-dialkylaminoalkylthio)benzenesulphonyl]-2-imidiazolidi none hydrochlorides.
    Pomarnacka E; Brzozowski Z; Gajewski F; Filczewski M; Oledzka K; Kosmala M; Sliwoska M
    Acta Pol Pharm; 1994; 51(4-5):393-401. PubMed ID: 7701953
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relevance of thromboxane-prostacyclin balance for cardiac rhythm disturbances.
    Mest HJ; Riedel A; Schneider S
    Prog Clin Biol Res; 1987; 242():185-90. PubMed ID: 3671381
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.